Allos Pharma Inc. Expands Intellectual Property Rights for Arbaclofen
/PRNewswire/ -- Allos Pharma Inc. ("Allos"), a biopharmaceutical company specializing in the development of treatments for rare neurological disorders,...
Source: prnewswire.com
Stay updated with breaking news from Allos Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Allos Pharma Inc. ("Allos"), a biopharmaceutical company specializing in the development of treatments for rare neurological disorders,...
/PRNewswire/ -- Allos Pharma Inc. ("Allos"), a biopharmaceutical company specializing in the development of treatments for rare neurological disorders,...
CAMBRIDGE, Mass., July 14, 2022 /PRNewswire/ -- Allos Pharma Inc ('Allos'), a late-stage pharmaceutical company developing therapeutics for neurod...